Polpharma Biologics S.A.
2 clinical trials · Sponsor
◉ Watch Polpharma Biologics S.A.
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® (NCT05771155) | Polpharma Biologics S.A. | 2023-07-24 |
| Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri® (NCT04115488) | Polpharma Biologics S.A. | 2019-10-01 |
Track Polpharma Biologics S.A. automatically
Every clearance here is in the API, with alerts when new ones post.